- Home
- USNA vs ARCT Comparison
USNA vs ARCT Comparison
Compare USNA & ARCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- USNA
- ARCT
- Stock Information
- Founded
- USNA 1992
- ARCT 2013
- Country
- USNA United States
- ARCT United States
- Employees
- USNA N/A
- ARCT N/A
- Industry
- USNA Medicinal Chemicals and Botanical Products
- ARCT Biotechnology: Pharmaceutical Preparations
- Sector
- USNA Health Care
- ARCT Health Care
- Exchange
- USNA Nasdaq
- ARCT Nasdaq
- Market Cap
- USNA 565.5M
- ARCT 320.8M
- IPO Year
- USNA 1996
- ARCT N/A
- Fundamental
- Price
- USNA $30.18
- ARCT $18.60
- Analyst Decision
- USNA Hold
- ARCT Strong Buy
- Analyst Count
- USNA 1
- ARCT 10
- Target Price
- USNA $36.00
- ARCT $50.88
- AVG Volume (30 Days)
- USNA 118.7K
- ARCT 493.8K
- Earning Date
- USNA 10-21-2025
- ARCT 11-06-2025
- Dividend Yield
- USNA N/A
- ARCT N/A
- EPS Growth
- USNA N/A
- ARCT N/A
- EPS
- USNA 1.80
- ARCT N/A
- Revenue
- USNA $899,221,000.00
- ARCT $122,122,000.00
- Revenue This Year
- USNA $13.94
- ARCT N/A
- Revenue Next Year
- USNA $7.95
- ARCT $28.92
- P/E Ratio
- USNA $17.02
- ARCT N/A
- Revenue Growth
- USNA 2.75
- ARCT N/A
- 52 Week Low
- USNA $23.10
- ARCT $8.04
- 52 Week High
- USNA $41.84
- ARCT $25.88
- Technical
- Relative Strength Index (RSI)
- USNA 44.92
- ARCT 62.40
- Support Level
- USNA $29.78
- ARCT $17.70
- Resistance Level
- USNA $30.93
- ARCT $19.50
- Average True Range (ATR)
- USNA 0.77
- ARCT 1.02
- MACD
- USNA -0.16
- ARCT -0.05
- Stochastic Oscillator
- USNA 19.47
- ARCT 72.97
About USNA USANA Health Sciences Inc.
Usana Health Sciences Inc is a direct selling and direct-to-consumer nutrition, personal health and wellness company. It developed and manufactured science-based nutritional, personal care and skincare products with a focus on promoting long-term health and wellness. The company has two reportable segments: direct selling and Hiya direct-to-consumer. The direct selling segment develops and manufactures high quality, science-based nutritional, personal care and skincare products with a focus on promoting long-term health and wellness in various geographic markets that are distributed through the direct selling channel. The Hiya direct-to-consumer segment is a provider of children's health and wellness products in the U.S. Key revenue is generated from Direct selling segment.
About ARCT Arcturus Therapeutics Holdings Inc.
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in one business segment, which includes all activities related to the discovery, development and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC, LUNAR-CF, LUNAR-FLU, and LUNAR-COV19.